Company Data
NeoGenomics Inc.
Ticker
NEO
Current Price
$18.05 -3.17%
Market Cap
$2.3B
Price Target
Refer to Report
Volume
1.7M
52wk Range
$6.65 - $19.76
Overview
NeoGenomics Inc operates a network of cancer-focused genetic testing laboratories in the United States as well as a laboratory in Switzerland. The company operates into two segments namely Clinical Services and Pharma Services. It offers types of genetic and molecular testing services namely Cytogenetics, Fluorescence In-Situ Hybridization, Flow cytometry, Immunohistochemistry, Molecular testing, Pathology consultation. The company generates revenue from Clinical Services.